Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Neuro-Oncology
|
September 7, 2017
Is the immune response a friend or foe for viral therapy of glioma?
Hideho Okada, Stephen H Thorne
Current Protocols in Cytometry
|
November 25, 2014
Practical Methods for Molecular In Vivo Optical Imaging
Hannah Chen, Stephen H Thorne
Seminars in Oncology
|
December 13, 2005
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects
Stephen H Thorne, Terry Hermiston, David Kirn
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 11, 2011
Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer
Baocheng Huang, Rachel Sikorski, Padma Sampath, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 6, 2008
Oncolytic adenoviruses for cancer gene therapy
Ta-Chiang Liu, Stephen H Thorne, David H Kirn
Current Gene Therapy
|
August 17, 2005
The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally?
Stephen H Thorne, David L Bartlett, David H Kirn
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 3, 2013
Regulating cytokine function enhances safety and activity of genetic cancer therapies
Hannah Chen, Padma Sampath, Weizhou Hou, et al.
Current Opinion in Molecular Therapeutics
|
August 27, 2005
Vaccinia virus and oncolytic virotherapy of cancer
Stephen H Thorne, Tae Ho Hwang, David H Kirn
Biochimica Et Biophysica Acta
|
March 11, 2008
Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses
Z Sheng Guo, Stephen H Thorne, David L Bartlett
Methods in Molecular Medicine
|
December 6, 2003
Replication-selective oncolytic adenoviruses
Gunnel Halldén, Stephen H Thorne, Jingping Yang, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Neuro-Oncology
|
September 7, 2017
Is the immune response a friend or foe for viral therapy of glioma?
Hideho Okada, Stephen H Thorne
Current Protocols in Cytometry
|
November 25, 2014
Practical Methods for Molecular In Vivo Optical Imaging
Hannah Chen, Stephen H Thorne
Seminars in Oncology
|
December 13, 2005
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects
Stephen H Thorne, Terry Hermiston, David Kirn
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 11, 2011
Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer
Baocheng Huang, Rachel Sikorski, Padma Sampath, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 6, 2008
Oncolytic adenoviruses for cancer gene therapy
Ta-Chiang Liu, Stephen H Thorne, David H Kirn
Current Gene Therapy
|
August 17, 2005
The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally?
Stephen H Thorne, David L Bartlett, David H Kirn
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 3, 2013
Regulating cytokine function enhances safety and activity of genetic cancer therapies
Hannah Chen, Padma Sampath, Weizhou Hou, et al.
Current Opinion in Molecular Therapeutics
|
August 27, 2005
Vaccinia virus and oncolytic virotherapy of cancer
Stephen H Thorne, Tae Ho Hwang, David H Kirn
Biochimica Et Biophysica Acta
|
March 11, 2008
Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses
Z Sheng Guo, Stephen H Thorne, David L Bartlett
Methods in Molecular Medicine
|
December 6, 2003
Replication-selective oncolytic adenoviruses
Gunnel Halldén, Stephen H Thorne, Jingping Yang, et al.
Page
of 4